Genetics: New autism mutations affect DNA packaging
Mutations in a gene associated with DNA packaging may lead to autism and intellectual disability, suggests a study published 16 February in Nature Genetics.
![](https://www.thetransmitter.org/wp-content/uploads/image-archive/images/images-2014/inbrief2014/2014ibadnp.jpg)
Facial features: People with ADNP mutations tend to have thin upper lips, prominent foreheads and broad nasal bridges.
Mutations in a gene associated with DNA packaging may lead to autism, according to a study published 16 February in Nature Genetics1.
People with mutations in the gene, ADNP, also tend to have intellectual disability, the study suggests.
The researchers analyzed DNA sequence data from multiple repositories and found that of 5,776 people with autism, 10 of them — or 0.17 percent — have mutations in ADNP. This is a relatively high prevalence, as even the most common autism mutations occur in less than 1 percent of people with the disorder.
All ten people with ADNPmutations have intellectual disability, and many had trouble feeding as infants, had developmental delays and have low muscle tone or congenital heart problems. ADNP mutations are also associated with thin upper lips, large foreheads and broad nasal bridges.
Experiments in mice implicate ADNP in the growth and development of neurons. Prior work has found that it recruits DNA packaging proteins from the BAF complex, otherwise known as the SWI/SNF complex. Packaging proteins perform such tasks as winding and unwinding tightly packed DNA to regulate gene expression.
When ADNP is mutated, it may be unable to aid in cellular processes as usual, leading to the symptoms observed in these individuals. Mutations to DNA-packaging proteins, including BAF proteins, have been linked to autism, suggesting their importance for understanding the disorder.
The researchers have set up a website to collect information about other people with autism who have an ADNP mutation. They plan to use the data to better understand various ADNP mutations’ functional and clinical effects.
References:
1. Helsmoortel C. et al. Nat. Genet. 46, 380-384 (2014) PubMed
Recommended reading
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
![Research image of astrocytes and microglia in mouse brains.](https://www.thetransmitter.org/wp-content/uploads/2024/08/1200-spotted-20240903-1024x683.webp)
X-chromosome genes; neurobiology of infant crying; MCHAT in preemies
![Illustration of a red pencil with a white eraser that is being used against a white sheet of paper.](https://www.thetransmitter.org/wp-content/uploads/2024/08/correction-1200-1024x692.webp)
Task swap prompts data do-over for autism auditory perception study
Explore more from The Transmitter
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
![Computer-generated illustration of a pencil.](https://www.thetransmitter.org/wp-content/uploads/2024/08/APpencil-1200-1024x692.webp)